VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PIII
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PIIIP3 Health Partners Inc.
$10.53$35M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

PIII logoP3 Health Partners Inc.(PIII)Earnings, Financials & Key Ratios

PIII•NASDAQ
$10.53
Price updated Jul 7, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustryPhysician platforms and value-based care
AboutP3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.Show more
  • Revenue$1.46B-2.8%
  • EBITDA-$186M+20.7%
  • Net Income-$148M-8.9%
  • EPS (Diluted)-45.26+16.3%
  • Gross Margin-9.89%-109.9%
  • EBITDA Margin-12.76%+18.4%
  • Operating Margin-18.53%+13.3%
  • Net Margin-10.14%-12.0%
  • ROE-3183.73%-6733.8%

PIII Price & Volume

P3 Health Partners Inc. (PIII) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Deficits Threaten Corporate Solvency

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity shortfall risk

Key Thesis Takeaways

  • P3 Health Partners faces a critical juncture as its core medical underwriting model fails to generate consistent profitability, evidenced by a recurring inability to maintain positive gross margins.
  • The company's reliance on intangible goodwill, which constitutes $473 million of its $674.2 million asset base, combined with a severe equity deficit of $143.5 million, suggests significant long-term structural distress.
  • Investors should monitor the company's precarious liquidity position, as the current cash balance of $25.5 million appears insufficient to support ongoing operations without immediate external capital intervention.

Verdict Logic

the company's reliance on a $25.5 million cash reserve to sustain a business model with a $649.9 million retained earnings deficit presents an imminent risk of insolvency.

PIII Growth Metrics

P3 Health Partners Inc. (PIII) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years24.33%
3 Years11.61%
TTM-0.87%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM8.27%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM23.06%

Return on Capital

10 Years-134.2%
5 Years-73.61%
3 Years-79.78%
Last Year-135.7%

Peers Comparison

Key metrics vs top competitors for P3 Health Partners Inc. (PIII)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PIII logoPIIIP3 Health Partners Inc.Current
$10.53$34.69M-0.23-2.76%-10.14%-3183.73%—
AGIO logoAGIOAgios Pharmaceuticals, Inc.
$44.01$2.62B-6.1848.03%-639.84%-34.11%—
ALHC logoALHCAlignment Healthcare, Inc.
$24.05$4.91B-6500.0046.06%0.47%11.5%—
OSCR logoOSCROscar Health, Inc.
$31.12$8.07B-18.4127.5%-0.3%-3.26%—
CNC logoCNCCentene Corporation
$66.12$32.65B-4.8519.44%-3.25%-28.6%—
MOH logoMOHMolina Healthcare, Inc.
$232.90$12.13B26.1111.75%0.42%4.44%—

Compare PIII vs Peers

P3 Health Partners Inc. (PIII) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AGIO

Most directly comparable listed peer for PIII.

Scale Benchmark

vs UNH

Larger-name benchmark to compare PIII against a more recognizable public peer.

Peer Set

Compare Top 5

vs AGIO, ALHC, OSCR, CNC

PIII SEC Filings & Documents

P3 Health Partners Inc. (PIII) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 15, 2026·SEC

Material company update

May 14, 2026·SEC

Material company update

Apr 28, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 26, 2026·SEC

FY 2025

Mar 28, 2025·SEC

FY 2024

Mar 28, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 14, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 14, 2025·SEC

Get notified when PIII posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PIII Frequently Asked Questions

P3 Health Partners Inc. (PIII) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is P3 Health Partners Inc.'s revenue?

P3 Health Partners Inc. (PIII) reported $1.47B in revenue for fiscal year 2025. This represents a 912% increase from $145.5M in 2019.

How fast is P3 Health Partners Inc. growing?

P3 Health Partners Inc. (PIII) saw revenue decline by 2.8% over the past year.

Is PIII profitable?

P3 Health Partners Inc. (PIII) reported a net loss of $126.2M for fiscal year 2025.

Dividend & Returns
What is PIII's return on equity?

P3 Health Partners Inc. (PIII) has a return on equity (ROE) of -3183.7%. Negative ROE indicates the company is unprofitable.

What is P3 Health Partners Inc.'s free cash flow?

P3 Health Partners Inc. (PIII) had negative free cash flow of $85.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in PIII back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →